Shares of Proto Labs, Inc. (NYSE:PRLB) have received a consensus rating of “Hold” from the six analysts that are currently covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 1-year price objective among brokerages that have issued a report on the stock in the last year is $98.67.
Several research firms have recently issued reports on PRLB. Zacks Investment Research raised shares of Proto Labs from a “hold” rating to a “buy” rating and set a $120.00 price target for the company in a research note on Saturday, January 13th. Piper Jaffray Companies reaffirmed a “hold” rating and set a $84.00 price target on shares of Proto Labs in a research note on Thursday, December 14th. BidaskClub downgraded shares of Proto Labs from a “strong-buy” rating to a “buy” rating in a research note on Friday, October 6th. Finally, Craig Hallum set a $92.00 price target on shares of Proto Labs and gave the company a “hold” rating in a research note on Monday, November 27th.
In related news, VP Robert Bodor sold 4,000 shares of Proto Labs stock in a transaction on Monday, December 11th. The shares were sold at an average price of $94.79, for a total transaction of $379,160.00. Following the completion of the transaction, the vice president now owns 20,578 shares of the company’s stock, valued at $1,950,588.62. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Rainer Gawlick sold 1,500 shares of Proto Labs stock in a transaction on Tuesday, November 21st. The stock was sold at an average price of $90.31, for a total transaction of $135,465.00. Following the transaction, the director now directly owns 6,925 shares of the company’s stock, valued at approximately $625,396.75. The disclosure for this sale can be found here. Insiders have sold 19,556 shares of company stock valued at $1,814,101 in the last three months. 7.78% of the stock is owned by insiders.
Proto Labs (NYSE:PRLB) traded up $3.20 during mid-day trading on Tuesday, hitting $111.70. 179,331 shares of the stock traded hands, compared to its average volume of 129,531. The company has a market capitalization of $2,890.00, a P/E ratio of 63.47, a P/E/G ratio of 2.36 and a beta of 1.07. Proto Labs has a 12-month low of $48.00 and a 12-month high of $111.80.
Proto Labs (NYSE:PRLB) last released its quarterly earnings results on Thursday, October 26th. The industrial products company reported $0.56 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.52 by $0.04. The firm had revenue of $88.10 million during the quarter, compared to the consensus estimate of $85.68 million. Proto Labs had a net margin of 14.53% and a return on equity of 11.63%. The company’s revenue for the quarter was up 12.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.51 earnings per share. equities research analysts anticipate that Proto Labs will post 1.89 earnings per share for the current year.
COPYRIGHT VIOLATION NOTICE: “Proto Labs, Inc. (PRLB) Receives $98.67 Average Price Target from Analysts” was published by Ticker Report and is the property of of Ticker Report. If you are reading this story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this story can be viewed at https://www.tickerreport.com/banking-finance/3146655/proto-labs-inc-prlb-receives-98-67-average-price-target-from-analysts.html.
About Proto Labs
Proto Labs, Inc is an e-commerce driven digital manufacturer of on-demand three dimensional (3D) printed, computer numerical control (CNC) machined and injection-molded custom parts for prototyping and short-run production. The Company’s geographic segments include the United States, Europe and Japan.
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.